KRAS and neoplasm: Contrary to our expectation that inactivation of these negative regulators would have a greater effect on tumors driven by the weaker KRAS G12C variant, inactivation of Nf1 or KrasWT increased KRAS G12C- and KRAS G12D-driven tumor growth to the same extent.